Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 215,456 | 140,407 | 92,852 | 108,481 | 88,559 |
| Receivables | 46,745 | 120,370 | 86,172 | 39,768 | 81,886 |
| TOTAL | $274,178 | $273,843 | $191,753 | $160,579 | $182,368 |
| Non-Current Assets | |||||
| PPE Net | 3,408 | 3,666 | 3,929 | 4,256 | 4,495 |
| Intangibles | 2,040 | 2,247 | 2,453 | 2,658 | 2,860 |
| Other Non-Current Assets | 117,275 | 116,306 | 144,811 | 159,720 | 161,185 |
| TOTAL | $122,723 | $122,219 | $151,193 | $166,634 | $168,540 |
| Total Assets | $396,901 | $396,062 | $342,946 | $327,213 | $350,908 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 199,680 | 199,506 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,898 | 1,613 | 1,389 | 5,827 | 2,127 |
| Accrued Expenses | 36,388 | 38,148 | 28,584 | 39,066 | 33,530 |
| Other current liabilities | N/A | N/A | 199,332 | N/A | N/A |
| TOTAL | $242,218 | $242,503 | $232,525 | $48,097 | $38,846 |
| Non-Current Liabilities | |||||
| Long Term Debt | 385,000 | 385,000 | 385,000 | 385,000 | 385,000 |
| Other Non-Current Liabilities | 31,518 | 32,716 | 33,583 | 228,169 | 228,397 |
| TOTAL | $416,518 | $417,716 | $418,583 | $613,169 | $613,397 |
| Total Liabilities | $658,736 | $660,219 | $651,108 | $661,266 | $652,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163,058 | 162,679 | 162,434 | 161,820 | 161,809 |
| Common Shares | 163 | 163 | 162 | 162 | 160 |
| Retained earnings | -1,673,718 | -1,671,442 | -1,711,522 | -1,735,121 | -1,697,735 |
| Other shareholders' equity | -1,060 | -1,714 | -2,026 | 294 | 923 |
| TOTAL | $-261,835 | $-264,157 | $-308,162 | $-334,053 | $-301,335 |
| Total Liabilities And Equity | $396,901 | $396,062 | $342,946 | $327,213 | $350,908 |